GenMark Diagnostics Announces Commercial Launch of its ePlex® Respiratory Pathogen Panel 2 (RP2)
29. Juni 2020 07:00 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., June 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced that its...
GenMark Diagnostics Chosen as Primary Provider of Rapid Diagnostic Testing for Vidant Health
16. Juni 2020 08:00 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, has been selected by...
GenMark Diagnostics to Participate in Upcoming Investor Conferences
27. Mai 2020 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a molecular diagnostics company focused on developing and commercializing...
GenMark Diagnostics Announces Closing of $80 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
11. Mai 2020 16:01 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a molecular diagnostics company focused on developing and commercializing...
GenMark Prices Public Offering of Common Stock
06. Mai 2020 22:59 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a molecular diagnostics company focused on developing and commercializing...
GenMark Commences Public Offering of Common Stock
06. Mai 2020 16:01 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a molecular diagnostics company focused on developing and commercializing...
GenMark Diagnostics Reports First Quarter 2020 Results
04. Mai 2020 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. ("GenMark" or the "Company") (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing...
GenMark Diagnostics Announces Scott Mendel Appointed CEO
04. Mai 2020 16:03 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...
GenMark Diagnostics to Report First Quarter 2020 Financial Results on May 4, 2020
22. April 2020 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., April 22, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its first quarter earnings results after market close...
GenMark Diagnostics Provides Preliminary Financial and Operational Results for First Quarter 2020 and Increases 2020 Revenue Guidance
07. April 2020 16:03 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., April 07, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...